Cardiovascular Effects of Chronic Sildenafil (Viagra) Treatment in Diabetic Subjects With Endothelial Dysfunction
Phase of Trial: Phase IV
Latest Information Update: 10 Mar 2016
At a glance
- Drugs Sildenafil (Primary)
- Indications Diabetic cardiomyopathy
- Focus Pharmacodynamics
- Acronyms CECSID
- 10 Mar 2016 Results published in the Journal of Clinical Endocrinology and Metabolism
- 14 May 2012 Actual patient number is 59 according to ClinicalTrials.gov.
- 14 May 2012 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.